Biodexa Pharmaceuticals (BDRX)

• Market cap: $2.45M
• 1 day: 1.23%
• 5 days: 1.55%
• 1 month: -15.68%
• 3 months: -44.41%
• 6 months: -84.81%
• Year to date: -73.33%
• 1 year: -95.28%
• 5 years: -100%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Employees: 11